Treating neuroblastoma
Clinical update Previous     Next

Treating neuroblastoma

Essential facts

The National Institute for Health and Care Excellence (NICE) has recommended the drug dinutuximab beta for the treatment of high-risk neuroblastoma – a rare type of cancer that mainly affects children and young people.

Cancer Nursing Practice. 17, 5,10-10. doi: 10.7748/cnp.17.5.10.s8

You need a subscription to read the full article